AssetMark’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.05K Buy
16
+4
+33% +$302 ﹤0.01% 3221
2026
Q2
$878 Hold
12
– – ﹤0.01% 3174
2026
Q1
$767 Hold
12
– – ﹤0.01% 3092
2025
Q4
$953 Hold
12
– – ﹤0.01% 2950
2025
Q3
$793 Hold
12
– – ﹤0.01% 2836
2025
Q2
$636 Hold
12
– – ﹤0.01% 2698
2025
Q1
$596 Buy
+12
New +$667 ﹤0.01% 2385

Other funds holding IRON

AssetMark's IRON Position: Q3 2026 in Review

AssetMark increased its Disc Medicine (IRON) stake by 33% in Q3 2026, buying an estimated $302 and bringing the position to 16 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #3221.

AssetMark first reported a position in IRON in Q1 2025 and has held it in 7 quarters since. 150 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • AssetMark held 16 shares of Disc Medicine worth $1.05K as of Q3 2026.
  • AssetMark bought 4 Disc Medicine shares in Q3 2026, an estimated $302.
  • Disc Medicine made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3221 holding.
  • AssetMark first reported a position in Disc Medicine in Q1 2025 and has held it in 7 quarters since.
  • 150 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.